key: cord-0734152-hlwlzgfp authors: Senapati, Jayastu; Aggarwal, Mukul; Louis, Liji; Mirza, Salim; Kumar, Pradeep; Dhawan, Rishi; Dass, Jasmita; Vishwanathan, Ganesh K.; Pandey, Hem Chandra; Coshic, Poonam; Tyagi, Seema; Seth, Tulika; Mahapatra, Manoranjan title: Transfusion practices during the COVID-19 pandemic: an experience from a hematology daycare in India date: 2020-11-26 journal: Transfus Apher Sci DOI: 10.1016/j.transci.2020.103025 sha: 8eb1573975899fdc3f728393551f36548ca0d77c doc_id: 734152 cord_uid: hlwlzgfp The Coronavirus disease-19 (COVID-19) pandemic has in multiple ways affected healthcare delivery to non-COVID patients throughout the world. Adequate transfusion services are fundamental in ongoing therapy of patients with hematological ailments. We present the transfusion services in the hematology daycare under the department of Hematology and supported by the Blood Bank at our institution for the period 12th April 2020- 30th June 2020, which saw the stringent lockdown and unlocking Phase I in India, declared in lieu of the pandemic. A 56% reduction in total transfusion sessions was observed in 2020 (588 sessions given to 176 patients) compared to 1336 sessions in 516 patients over the same period in 2019. The reductions were seen across the different blood components (packed red blood cells [PRBC]: 585 vs. 1840, platelet rich plasma: 372 vs. 1313, single donor platelet 18 vs. 16), with a significant reduction in the mean PRBC transfused per PRBC transfusion session (1.11 vs 1.99, p<0.001) in 2020, compared to 2019. There were however no major differences in the transfusion practices across the different phases of the lockdown. Our study highlights the detrimental reduction in transfusion services due to the COVID-19 pandemic and related lockdown and showcases the remedial strategies taken to maximize transfusion support to patients during this period. Our observations might help to provide insights to adequately combat possible similar adverse situations in the future. Keywords: COVID-19 pandemic, transfusion, blood bank, lockdown, India The Corona virus disease-19 (COVID-19) pandemic has imposed never before seen challenges to healthcare delivery. Together with the diversion of healthcare resources towards the care of COVID-19 patients, the lack of easy commute to the hospital and reduced inpatient/outpatient services to ensure physical distancing had led to significant hurdles in the care of non-COVID patients [1] . The COVID pandemic and subsequent lockdown led to significant capsizing of transfusion support throughout the world leading to impediments in cancer care, delay in surgeries and increased morbidities in transfusion dependent patients [2, 3] . This is especially relevant for patients with hematological disorders who need regular transfusion support as part of their ongoing treatment for cancers, thalassemia, aplastic anemia etc. The nation-wide lockdowns in India started from 24 th March 2020 with the Phase I lockdown extending till 14 th April. Various phases of lockdown continued till May end, with increasing ease on restrictions followed by unlock phase. We report the transfusion services provided by the Hematology day care from our centre during the period 12 th April to 30 th June 2020 and compare the transfusion For the present year, we assessed the cumulative patient numbers who were transfused, age and gender distribution, underlying hematological ailment, the total blood products administered, the median hemoglobin at which transfusion was done in patients with thalassemia and bone marrow failure syndromes like aplastic anemia. The data was tabulated and analysed on Microsoft Excel (version 14.1.0). A twosided t-test was used for comparing dual variables and one-sided ANOVA for multiple variables. A p value < 0.05 was considered significant. The study has been approved by Institutional Ethics committee. During the earlier part of first lockdown period, the Hematology day care services were closed as an emergency measure and it restarted from 12 th April 2020. As mentioned above, the changes to the transfusion practices in daycare were instituted to enable physical distancing as per hospital administration guidance. From 12 th April to 30 th June 2020 a total of 588 transfusion sessions were administered to 176 patients compared to 1336 sessions in 516 patients during the same dates in 2019 (Table 1 ). The median age for a patient in a transfusion session in 2020 was 14 years (6 months-74 years) compared to 18 years (5 months to 87 years) in 2019 (Table 1) Of the total transfusion sessions, 41% were administered to patients with thalassemia We aimed to study the effect of the COVID-19 pandemic and lockdown on transfusion services in the Hematology daycare. The COVID 19 pandemic led to reduction in blood bank inventory throughout the world in view of reduced voluntary blood donations and secondary to the deferral of elective orthopedic and surgical procedures due to the pandemic [4] . against which significant replacement donations are done in the blood bank. Similar pattern was observed in our blood bank as well. Our data shows that there was a significant reduction in the transfusion sessions as well as the number of blood product transfused per session compare to 2019. Given the requirement for stringent physical distancing the transfusion slots were reduced in the daycare. Voluntary and replacement donations to the blood bank had also ebbed. In an effort to ensure transfusion to the maximum number of patients we tried the following measures: J o u r n a l P r e -p r o o f 1) Increasing the transfusion batches in daycare from 2 to 3 by careful time management as has been mentioned under the study setting before. This enabled to maintain physical distance during any batch (by reducing the slots per batch to 50%), yet transfusing the maximum number of patients in a given 24-hour cycle. 2) The threshold for transfusion in thalassemia and aplastic anemia were changed as well to accommodate more patients, albeit deviating from laid down transfusion guidelines [5] . 3) Patients who were not able to commute due to restrictions were encouraged to take transfusions at their local hospitals and were provided telephonic consultations to guide their transfusion needs. The reduction in blood donations and hence availability of blood components has been observed throughout the world, but due to deferment of elective surgical procedures, the demand for transfusion products had also decreased [6, 7] . This could also lead to overall decrease in blood components utilization across the hospital departments, as reported by 75% respondents in a worldwide survey, though the situation may vary in centres where a significant number of hematology/oncology patients undergo treatment routinely [8] . Murphy C et al reported 42% drop in usage J o u r n a l P r e -p r o o f of PRBC, FFP and cryoprecipitate (not for PRP) mostly limited to general operating rooms, while their outpatient transfusions remained steady [9] . We believe that hematology patients with aplastic anemia or thalassemia who need continuous transfusion support to maintain quality of life, as well as hematological malignancies patients who need blood product support to maintain continuity of chemotherapy regimens were bound to be adversely affected by this pandemic. As a department policy, induction of AML/ALL and consolidation of AML are given as inpatient ward, so their data is not included with daycare statistics. Transfusions in other phases of ALL and other hematological malignancies are done in daycare. This explains overall low number of malignancy patients in the study. Indeed, despite these directives and efforts, the transfusion services for hematology patients suffered a hit due to the reduced inventory of blood products at certain times and reduction in the transfusion capacity of the daycare as well as difficulties in patient/donor movement across cities. We were able to provide less than half the The present pandemic has posed challenges to non-COVID healthcare delivery across the world. Streamlining transfusion services to cater to critical healthcare demands during such periods is important for preventing treatment interruption of hematology/oncology patients who are dependent on them for routine life and continuation of disease specific therapy. Our study highlighted the significant reduction in blood components administered during the lockdown and early unlocking period compared to a similar period last year. Covid-19: collateral damage of lockdown in India Managing Cancer Care during the COVID-19 Pandemic and Beyond Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario The blood supply management amid the COVID-19 outbreak Blood and blood product use during COVID-19 infection The effect of the COVID-19 pandemic on the adequacy of blood supply: Specialists in Transfusion Medicine need to establish models of preparedness Vox Sanguinis International Forum on Hospital Transfusion Services' Response to COVID-19. Vox Sang Tools for rapid analysis of blood usage and inventory during the COVID-19 pandemic Guidance on maintaining a safe and adequate blood supply during the coronavirus disease 2019 (COVID-19) pandemic and on the collection of COVID-19 convalescent plasma: interim guidance World Health Organization